Briefing Information for the November 1, 2017 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
FDA
- FDA Briefing Information for the November 1, 2017 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee
- Errata to the FDA Briefing Information for the November 1, 2017 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee